NEUROCOGNITIVE FUNCTIONING IN EORTC BRAIN TUMOR GROUP RANDOMIZED PHASE II TAVAREC TRIAL (EORTC 26091, NCT01164189) ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB in 1p/19q INTACT RECURRENT GRADE II AND III GLIOMAS

Martin Klein, Jaap C. Reijneveld, Ahmed Idbaih, Walter Taal, Paul M. Clement, Filip de Vos, Antje Wick, Paul Mulholland, Martin J. B. Taphoorn, Joanne Lewis, Michael Weller, Tina Verschuere, Vassilis Golfinopoulos, Thierry Gorlia, Martin van den Bent

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)139-139
JournalNeuro-Oncology
Volume19
Publication statusPublished - Nov 2017

Cite this